ISOPP member expertise needed to serve on an ISOPP Task Force reviewing / endorsing the ADDIKD draft guideline.  ISOPP has been invited by the NSW Cancer Institute to review/endorse the eviQ ‘Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD)’ draft guideline. Email by Tuesday, May 17, if you would like to serve on this time-limited opportunity.


Submitted by Lynne Nakashima, Chair, ISOPP Immunotherapy Task Force

The ISOPP Immunotherapy Task Force has been hard at work since the fall of 2020, developing resources to assist oncology pharmacy practitioners in managing the care of patients on immunotherapy.


Outgoing and Incoming President Messages - from Shaun O'Connor, Outgoing President and Evelyn Handel Zapata, Incoming President


ISOPP Members, the ISOPP quarterly Newsletter was distributed to your inbox on Friday April 8th. Read about updates and other important news from ISOPP!


ISOPP Position Paper on the role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions:

The position paper developed by the Immunotherapy Task Force has been published online ahead of print by JOPP. View the paper on the ISOPP website here.


The minutes of ISOPP’s 2022 virtual Annual General Meeting (AGM), which took place on Saturday, March 5 during the ISOPP 2022 Virtual Symposium, are available online in the member’s section of the website.

Or watch a recording of the meeting on the website.


Hot off the press! The revised ISOPP Standards of Practice has been published.

The revised ISOPP Standards of Practice document has been published in the Journal of Oncology Pharmacy Practice and posted to ISOPP’s website.


Welcome aboard to our newly elected Secretariat members.


ISOPP Members, the ninety-third issue of the Virtual Journal Club (VJC) is available on the International Society of Oncology Pharmacy Practitioners (ISOPP) website. To access it, visit the